Moneycontrol PRO
HomeNewsBusinessMarketsClosing Bell: Nifty ends 124 pts higher, Sensex up 378 pts; auto stocks biggest gainers
Live now
auto refresh

Closing Bell: Nifty ends 124 pts higher, Sensex up 378 pts; auto stocks biggest gainers

The Sensex was up 378.73 points at 36442.54, while Nifty was up 124.00 points at 10987.50.

March 05, 2019 / 15:38 IST
  • Moneycontrol.com
  • IndexPricesChangeChange%
    Sensex83,952.19484.53 +0.58%
    Nifty 5025,709.85124.55 +0.49%
    Nifty Bank57,713.35290.80 +0.51%
    Nifty 50 25,709.85 124.55 (0.49%)
    Fri, Oct 17, 2025
    Biggest GainerPricesChangeChange%
    Asian Paints2,507.8098.10 +4.07%
    Biggest LoserPricesChangeChange%
    Wipro240.90-12.91 -5.09%
    Best SectorPricesChangeChange%
    Nifty FMCG56616.40762.50 +1.37%
    Worst SectorPricesChangeChange%
    Nifty IT34950.70-580.40 -1.63%


  • March 05, 2019 / 15:35 IST

    Market at close

    : It is a strong close for benchmark indices on first day of the week as market was shut on Monday on account of Mahashivratri.

    The Sensex was up 378.73 points at 36442.54, while Nifty was up 124.00 points at 10987.50. About 2118 shares have advanced, 568 shares declined, and 152 shares are unchanged.

    Indiabulls Housing, Eicher Motors, Tata Motors, HPCL and BPCL were the top gainers on the Nifty, while losers were Wipro, Tech Mahindra, Infosys, HUL and Cipla.

    Midcap and smallcap gained 2-3 percent, respectively. Among the sectors, auto, metal and PSU bank indices led with 2-3 percent gain followed by energy, infra and pharma, while IT index lost over 1 percent.

  • March 05, 2019 / 15:27 IST

    Rupee gains further

    The Indian rupee is trading higher by43paiseat 70.48per dollar versus Friday's close 70.91.

  • March 05, 2019 / 15:25 IST

    JUST IN |

    Reserve Bank of India (RBI) has imposed an aggregate penalty of Rs 2 crore on Canara Bank.

  • March 05, 2019 / 15:18 IST

    ITC hikes prices

    ITC is likely to have hiked prices of Bristol, Flake Excel and Capstan Cigarettes, reports CNBC-TV18, quoting Sources.

  • March 05, 2019 / 15:16 IST

    JUST IN

    |Bank of Baroda has revised Marginal Cost of Funds Based Lending Rate (MCLR) w.e. f. March 7, 2019.

  • March 05, 2019 / 15:13 IST
  • March 05, 2019 / 15:11 IST

    Alembic Pharmaceuticals JV get USFDA approval

    Company's joint venture Aleor Dermaceuticals has received approval from the US Food & DrugAdministration (USFDA) for its Abbreviated New Drug Application (ANDA) Clobetasol Propionate Ointment USP, 0.05%.

  • March 05, 2019 / 15:08 IST

    ABB approves scheme of arrangement

    Board of the company has approved a scheme of arrangement amongst the company, ABB Power Products and Systems India and their respective shareholders and creditors, providing for the demerger of the company's power grids business to ABB Power Products and Systems India.

  • March 05, 2019 / 14:53 IST

    Tata Motors UK sales

    Jaguar UK sales up 34.4% at 991 units, JLR UK salesup 13.9% at 2,550 units and Land Rover UK sales up 3.9% at 1,559 units.

  • March 05, 2019 / 14:37 IST

    Market Update

    Benchmark indices continue to trade higher on Tuesday with Nifty around 10,950 level.

    At 14:24 hrs IST, the Sensex is up 274.18 points at 36337.99, while Nifty is up 94.40 points at 10957.90. About 1965 shares have advanced, 554 shares declined, and 143 shares are unchanged.

  • March 05, 2019 / 14:21 IST

    Lupin, Natco gets ANDA approval

    Lupin and Natco Pharma announced the final ANDA approval for lmatinib Mesylate Tablets, 100 mg (base) and 400 mg (base) from the United States Food and Drug Administration (FDA) to market a generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec Tablets, 100mg and 400mg.

  • March 05, 2019 / 14:08 IST
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347